These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36270987)

  • 21. LncRNA PTPRG-AS1 facilitates glycolysis and stemness properties of esophageal squamous cell carcinoma cells through miR-599/PDK1 axis.
    Wu K; Wang Z; Huang Y; Yao L; Kang N; Ge W; Zhang R; He W
    J Gastroenterol Hepatol; 2022 Mar; 37(3):507-517. PubMed ID: 34676588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
    Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
    J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA NCK1-AS1 functions as a ceRNA to regulate cell viability and invasion in esophageal squamous cell carcinoma via microRNA-133b/ENPEP axis.
    He XY; Wang XQ; Xiao QL; Liu D; Xu QR; Liu S
    Cell Cycle; 2023 Mar; 22(5):596-609. PubMed ID: 36412985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense lncRNA PCNA-AS1 promotes esophageal squamous cell carcinoma progression through the miR-2467-3p/PCNA axis.
    Hu T; Niu Y; Fu J; Dong Z; He D; Liu J
    Open Med (Wars); 2022; 17(1):1483-1494. PubMed ID: 36213440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional Role of a Novel Long Noncoding RNA
    Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
    Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
    [No Abstract]   [Full Text] [Related]  

  • 26. lncRNA BBOX1-AS1 silencing inhibits esophageal squamous cell cancer progression by promoting ferroptosis via miR-513a-3p/SLC7A11 axis.
    Pan C; Chen G; Zhao X; Xu X; Liu J
    Eur J Pharmacol; 2022 Nov; 934():175317. PubMed ID: 36216119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of long non-coding RNA SBF2-AS1 promotes cell progression in esophageal squamous cell carcinoma (ESCC) by repressing miR-494 to up-regulate PFN2 expression.
    Zhang Q; Pan X; You D
    Biol Open; 2020 Mar; ():. PubMed ID: 32229486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma.
    Huang L; Jiang X; Kang P; Wang Z; Leng K; Ji D; Xu Y; Wang H; Cui Y
    Cancer Manag Res; 2019; 11():7739-7749. PubMed ID: 31616187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA ZNF667-AS1 retards the development of esophageal squamous cell carcinoma via modulation of microRNA-1290-mediated PRUNE2.
    Zheng YJ; Liang TS; Wang J; Zhao JY; Zhai SN; Yang DK; Wang LD
    Transl Oncol; 2022 Jul; 21():101371. PubMed ID: 35504176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Li S; Wu X; Niu Y; Liang X; Yang L; Guo Y; Shen S; Liang J; Guo W
    Cell Death Dis; 2019 Dec; 10(12):930. PubMed ID: 31804468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.
    Lu YB; Jiang Q; Yang MY; Zhou JX; Zhang Q
    Oncotarget; 2017 Oct; 8(51):88804-88814. PubMed ID: 29179477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression.
    Shen Q; Jiang Y
    Biomed Pharmacother; 2018 Sep; 105():176-181. PubMed ID: 29857296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
    Zhou Y; Zhang Z; Wo M; Xu W
    Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YY1-induced upregulation of FOXP4-AS1 and FOXP4 promote the proliferation of esophageal squamous cell carcinoma cells.
    Li Y; Li T; Yang Y; Kang W; Dong S; Cheng S
    Cell Biol Int; 2020 Jul; 44(7):1447-1457. PubMed ID: 32159250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs.
    Zhang Y; Chen W; Pan T; Wang H; Zhang Y; Li C
    Biochem Biophys Res Commun; 2019 Apr; 511(3):566-572. PubMed ID: 30824187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway.
    Yang L; Ye Y; Chu J; Jia J; Qu Y; Sun T; Yin H; Ming L; Wan J; He F
    Cancer Manag Res; 2019; 11():4425-4435. PubMed ID: 31191005
    [No Abstract]   [Full Text] [Related]  

  • 38. LncRNA LOXL1-AS1 promotes esophageal squamous cell carcinoma progression by targeting DESC1.
    Li H; Chu J; Jia J; Sheng J; Zhao X; Xing Y; He F
    J Cancer; 2021; 12(2):530-538. PubMed ID: 33391449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis.
    Yao C; Cheng X; Guo X; Lu X; Bu F; Xu Y
    Cancer Cell Int; 2020; 20():463. PubMed ID: 32982585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis.
    Jia J; Li H; Chu J; Sheng J; Wang C; Jia Z; Meng W; Yin H; Wan J; He F
    J Cancer; 2021; 12(4):1200-1211. PubMed ID: 33442418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.